Janus Capital Management LLC cut its position in Aetna Inc. (NYSE:AET) by 9.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,429,861 shares of the company’s stock after selling 457,869 shares during the period. Janus Capital Management LLC owned approximately 1.34% of Aetna worth $565,014,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. increased its position in Aetna by 3,374.9% in the first quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock worth $3,917,344,000 after buying an additional 29,828,390 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Aetna by 3.8% in the first quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock worth $2,948,640,000 after buying an additional 838,578 shares during the last quarter. FMR LLC boosted its stake in shares of Aetna by 2.2% in the first quarter. FMR LLC now owns 7,903,233 shares of the company’s stock worth $1,008,059,000 after buying an additional 167,261 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Aetna by 3.9% in the first quarter. Bank of New York Mellon Corp now owns 4,378,982 shares of the company’s stock worth $558,540,000 after buying an additional 165,278 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Aetna by 0.6% in the first quarter. Dimensional Fund Advisors LP now owns 3,962,514 shares of the company’s stock worth $505,399,000 after buying an additional 21,953 shares during the last quarter. Hedge funds and other institutional investors own 91.73% of the company’s stock.
Shares of Aetna Inc. (AET) traded down 0.18% during mid-day trading on Friday, hitting $152.15. The stock had a trading volume of 1,791,311 shares. Aetna Inc. has a 1-year low of $104.59 and a 1-year high of $161.69. The stock’s 50-day moving average price is $154.28 and its 200 day moving average price is $138.79. The company has a market capitalization of $50.53 billion, a P/E ratio of 33.77 and a beta of 0.54.
Aetna (NYSE:AET) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.34 by $1.08. The company had revenue of $15.52 billion during the quarter, compared to analyst estimates of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The firm’s quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter last year, the company earned $2.21 earnings per share. On average, analysts predict that Aetna Inc. will post $9.52 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Thursday, July 13th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.31%. The ex-dividend date was Tuesday, July 11th. Aetna’s dividend payout ratio is 43.67%.
ILLEGAL ACTIVITY NOTICE: “Janus Capital Management LLC Has $565.01 Million Stake in Aetna Inc. (AET)” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.com-unik.info/2017/08/11/aetna-inc-aet-shares-sold-by-janus-capital-management-llc-updated-updated-updated.html.
AET has been the subject of a number of recent analyst reports. Royal Bank Of Canada reaffirmed a “buy” rating and set a $145.00 target price on shares of Aetna in a research report on Monday, April 24th. Bank of America Corporation reissued a “buy” rating and issued a $168.00 price objective (up from $160.00) on shares of Aetna in a research report on Wednesday, May 17th. Morgan Stanley started coverage on Aetna in a research report on Tuesday, June 6th. They issued an “overweight” rating and a $162.00 price objective for the company. Zacks Investment Research raised Aetna from a “hold” rating to a “buy” rating and set a $170.00 price objective for the company in a research report on Tuesday, July 4th. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $163.00 price objective (up from $157.00) on shares of Aetna in a research report on Friday, August 4th. Eight investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $157.09.
In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of Aetna stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the sale, the executive vice president now owns 33,563 shares of the company’s stock, valued at $5,008,606.49. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Chairman Mark T. Bertolini sold 103,547 shares of Aetna stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total value of $14,578,382.13. Following the sale, the chairman now directly owns 659,888 shares of the company’s stock, valued at approximately $92,905,631.52. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by company insiders.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
What are top analysts saying about Aetna Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aetna Inc. and related companies.